Back to search

Article

Clinical and Hemodynamic Characterization Super Responders to IV Prostacyclin in Pulmonary Arterial Hypertension

2021-02-08

Abstract excerpt

<h4>Background: </h4> Parenteral prostacyclins are the only therapy proven to extend survival in pulmonary arterial hypertension (PAH), yet at the bedside clinicians have no tools to predict which patients are most likely to benefit from this medication class. <h4>Methods: </h4>: We retrospectively analyzed all PAH patients treated with IV epoprostenol therapy at our center from 1/1/1996 to 12/31/2016. We analyzed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b399aeb5-31d4-53a5-bce2-09e73451ac36
DOI
10.21203/rs.3.rs-70022/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and Hemodynamic Characterization Super Responders to IV Prostacyclin in Pulmonary Arterial HypertensionDOI 10.21203/rs.3.rs-70022/v2
Select a neighboring publication to make it the new centre.